Monster Beverage
MNST
$97.50
-2.44%
Monster Beverage Corporation is a leader in the energy drink category within the non-alcoholic ready-to-drink beverage market, with brands like Monster Energy, Monster Ultra, Java Monster, and Reign. The company distinguishes itself through a strong brand portfolio and a strategic partnership with Coca-Cola, which owns a 20% stake and handles distribution globally. Investor attention is currently focused on Monster's ability to sustain double-digit revenue growth amid intensifying competition from challengers like Celsius, while its expanding alcohol brands and robust margins provide a buffer. Recent news highlights the debate between Monster's stability versus Celsius's higher growth potential, keeping the stock in focus.…
MNST
Monster Beverage
$97.50
Related headlines
Investment Opinion: Should I buy MNST Today?
Rating: Hold. Monster Beverage is a high-quality company with accelerating growth and strong margins, but its premium valuation and average analyst target suggesting downside warrant caution. The consensus analyst rating is Buy with an average target of $91.90, implying -5.7% from the current price of $97.50.
Supporting evidence includes: (1) revenue growth accelerating to 26.9% YoY, (2) net margin of 24.2% vs. industry average ~15%, (3) zero debt and $2.072B free cash flow, and (4) trailing P/E of 39.3x, a 79% premium to the industry. The PEG ratio of 1.31 suggests the premium is partially justified by growth, but the stock trades near the high end of its 5-year P/E range.
Key risks: (1) competitive pressure from Celsius could slow growth, (2) valuation compression if growth decelerates, and (3) any earnings miss could lead to a -34% decline toward the low analyst target of $64. This Hold would upgrade to Buy if the P/E compresses below 30x or if revenue growth sustains above 20%, and downgrade to Sell if growth falls below 10% or margins contract. Overall, Monster is fairly valued relative to its growth but overvalued relative to the industry, making it a hold for existing investors and a cautious buy for new investors on pullbacks.
Sign up to view all
MNST 12-Month Price Forecast
Monster's strong fundamentals are offset by a premium valuation that limits upside potential. The accelerating revenue growth and industry-leading margins support the bull case, but the stock's price already reflects these strengths. The base case of 15-20% growth and modest multiple compression is most likely, leading to a neutral stance. Upgrades would require sustained 25%+ growth or a pullback to more attractive valuations, while downgrades would follow competitive losses or margin erosion.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Monster Beverage's 12-month outlook, with a consensus price target around $93.36 and implied upside of -4.3% versus the current price.
Average Target
$93.36
0 analysts
Implied Upside
-4.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$64 - $113
Analyst target range
Monster is covered by 24 analysts, with a consensus recommendation of 'Buy' (mean rating 2.07 on a 1-5 scale, where 1 is Strong Buy). The average target price is $91.90, implying a -5.7% downside from the current price of $97.50, suggesting the stock may be slightly ahead of fundamentals. The distribution includes 10 Buy/Overweight ratings and 2 Neutral ratings, with no Sell ratings, indicating a bullish but cautious consensus. The target range spans from a low of $64.00 to a high of $113.00, a wide spread of $49.00, reflecting high uncertainty. The high target of $113.00 implies 15.9% upside and likely assumes continued market share gains and margin expansion, while the low target of $64.00 (-34.4% downside) may price in competitive pressure from Celsius or a slowdown in growth. Recent ratings from Citigroup (Buy), Wells Fargo (Overweight), and Morgan Stanley (Overweight) reinforce positive sentiment, while JP Morgan and UBS remain Neutral. The wide spread suggests divergent views on the stock's future performance.
Drowning in data?
Find the real signal!
Bulls vs Bears: MNST Investment Factors
Monster Beverage presents a compelling bull case with accelerating revenue growth, industry-leading margins, and a fortress balance sheet. However, the stock's premium valuation (39.3x trailing P/E vs. industry 22.0x) and average analyst target implying downside suggest much of the good news is already priced in. The central tension is whether Monster can sustain its growth momentum against intensifying competition from Celsius and other challengers. Currently, the bull case has stronger evidence given the accelerating growth and profitability, but the valuation leaves little room for error, making the risk-reward balanced.
Bullish
- Accelerating Revenue Growth: Q1 2026 revenue grew 26.9% YoY to $2.353B, accelerating from 14.9% in Q1 2025 and marking the fourth consecutive quarter of sequential acceleration. This outpaces the broader beverage industry and demonstrates strong market share gains.
- Industry-Leading Profitability: Net margin of 24.2% and operating margin of 31.0% in Q1 2026 are well above beverage industry averages. Gross margin improved to 55.0%, reflecting pricing power and cost control.
- Debt-Free Balance Sheet: Monster has zero debt (debt-to-equity ratio of 0) and $2.072B in trailing free cash flow. This provides financial flexibility for reinvestment, acquisitions, or share repurchases.
- Strong Momentum Near Highs: The stock is up 65% over the past year and trades at 97.2% of its 52-week high of $100.34. With a beta of 0.53, it offers market-beating returns with lower volatility.
Bearish
- Premium Valuation Limits Upside: Trailing P/E of 39.3x is a 79% premium to the industry average of 22.0x. The average analyst target of $91.90 implies -5.7% downside from the current price of $97.50.
- Intense Competition from Celsius: Celsius offers higher growth potential in the energy drink market, potentially pressuring Monster's market share. Recent news highlights the debate between Monster's stability and Celsius's growth.
- Wide Analyst Target Range: Analyst targets range from $64.00 to $113.00, a spread of $49.00, indicating high uncertainty. The low target implies 34.4% downside, reflecting risks from competitive pressure or growth deceleration.
- Near-Term Downside Risk: The stock's 52-week low of $58.09 represents a potential 40.4% decline from current levels. With a short ratio of 3.27, bearish sentiment exists despite the strong uptrend.
MNST Technical Analysis
Monster Beverage is in a sustained uptrend, with the stock up 65.0% over the past year, significantly outperforming the S&P 500's 18.4% gain. The current price of $97.50 sits at 97.2% of its 52-week range ($58.09–$100.34), indicating the stock is near its highs and reflecting strong momentum, though it may be approaching overbought territory. The 1-year relative strength of 46.7% underscores its market-beating performance. Short-term momentum is accelerating, with a 1-month price change of +6.4% and a 3-month change of +27.1%, both outpacing the S&P 500's 0.3% and 4.7% gains, respectively. This acceleration aligns with the longer-term uptrend, suggesting no divergence; the stock has gained 24.7% over six months, confirming consistent buying pressure. The beta of 0.53 indicates the stock is less volatile than the market, which may appeal to risk-averse investors. Key support lies near the 52-week low of $58.09, while resistance is at the 52-week high of $100.34. A breakout above $100.34 would signal a continuation of the uptrend, potentially opening room for further gains. Conversely, a breakdown below recent support around $95 could indicate a short-term pullback, but given the low beta and strong trend, such a move may be limited.
Beta
0.53
0.53x market volatility
Max Drawdown
-17.7%
Largest decline past year
52-Week Range
$58-$100
Price range past year
Annual Return
+65.0%
Cumulative gain past year
| Period | MNST Return | S&P 500 |
|---|---|---|
| 1m | +6.4% | -0.5% |
| 3m | +27.1% | +4.9% |
| 6m | +24.7% | +9.7% |
| 1y | +65.0% | +18.4% |
| ytd | +28.0% | +9.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MNST Fundamental Analysis
Monster's revenue trajectory remains robust, with Q1 2026 revenue of $2.353 billion, up 26.9% year-over-year, accelerating from the 14.9% growth in Q1 2025. The multi-quarter trend shows sequential acceleration: Q2 2025 revenue was $2.112 billion (+13.8% YoY), Q3 2025 was $2.197 billion (+16.8% YoY), and Q4 2025 was $2.131 billion (+17.6% YoY). The Monster Energy Drinks segment drove the bulk of revenue at $2.189 billion, while Alcohol Brands contributed $32.7 million and Strategic Brands added $126.7 million. This growth trajectory supports the investment case, as Monster continues to gain share in the expanding energy drink market. Profitability is strong, with net income of $569.5 million in Q1 2026, up from $443.0 million in Q1 2025, and a net margin of 24.2%, which is healthy for the beverage industry. Gross margin improved to 55.0% in Q1 2026 from 54.9% in Q1 2025, while operating margin expanded to 31.0% from 30.7%, indicating operating leverage. The company is solidly profitable with no debt, as the debt-to-equity ratio is 0. Free cash flow (TTM) stands at $2.072 billion, providing ample liquidity for internal growth and share repurchases. The current ratio of 3.70 and ROE of 23.1% reflect a strong balance sheet and efficient capital use, reducing financial risk.
Quarterly Revenue
$2.4B
2026-03
Revenue YoY Growth
+26.9%
YoY Comparison
Gross Margin
55.0%
Latest Quarter
Free Cash Flow
$2.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MNST Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 39.3x, while the forward P/E is 37.6x, implying the market expects earnings growth to continue, albeit at a slightly lower multiple. The gap between trailing and forward P/E suggests modest growth expectations, consistent with the PEG ratio of 1.31. Compared to the industry average P/E of 22.0x (estimated from sector data), Monster trades at a 79% premium, reflecting its superior growth and profitability. The premium is justified by its 26.9% revenue growth and 24.2% net margin, which are well above industry averages. Historically, Monster's trailing P/E of 39.3x is near the upper end of its 5-year range (roughly 30x–45x), indicating the market is pricing in optimistic expectations. This is supported by the stock's strong performance and growth trajectory, but it also leaves less room for error.
PE
39.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 30x~47x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
27.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Monster's financial risk is low due to zero debt and strong free cash flow of $2.072B. However, the premium valuation (39.3x P/E) means any earnings miss could trigger a sharp correction. Revenue concentration in energy drinks (93% of Q1 2026 revenue from Monster Energy Drinks) exposes the company to category-specific slowdowns. Operating margin expansion from 30.7% to 31.0% YoY shows leverage, but input cost inflation could pressure gross margins if not passed through.
Market & Competitive Risks: The energy drink market is highly competitive, with Celsius gaining share through higher growth rates. Monster's beta of 0.53 suggests lower market correlation, but a sector rotation away from growth stocks could compress its P/E multiple. Regulatory risks include potential FDA scrutiny of caffeine content or marketing practices. The wide analyst target range ($64-$113) reflects divergent views on competitive dynamics.
Worst-Case Scenario: If Celsius continues to gain share and Monster's revenue growth decelerates below 10%, the stock could re-rate to its 52-week low of $58.09, representing a 40.4% decline from current levels. This scenario would likely involve multiple compression to the industry average P/E of 22x, implying a price around $55-60 based on forward earnings of $2.60 per share.
FAQ
The primary risk is competitive pressure from Celsius, which offers higher growth potential and could erode Monster's market share. Second, the premium valuation (39.3x P/E) leaves the stock vulnerable to multiple compression if growth decelerates, with the low analyst target of $64 implying 34.4% downside. Third, regulatory risks include potential FDA limits on caffeine content, which could impact the energy drink category. Fourth, the stock's low beta (0.53) means it may underperform in strong bull markets. The most severe risk is a sustained growth slowdown below 10%, which could trigger a re-rating to the industry average P/E of 22x.
Analysts have a consensus Buy rating with an average target of $91.90, implying -5.7% downside from the current price of $97.50. The bull case (25% probability) targets $100-$113, driven by sustained 25%+ growth and margin expansion. The base case (50% probability) targets $85-$100, with growth moderating to 15-20% and modest multiple compression. The bear case (25% probability) targets $64-$80, assuming competitive losses and growth below 10%. The most likely scenario is the base case, where the stock trades near the average target as growth normalizes. Key assumptions include energy drink market growth of 8-10% and Monster maintaining its market share.
Monster Beverage trades at a trailing P/E of 39.3x, a 79% premium to the beverage industry average of 22.0x. Its forward P/E of 37.6x and PEG ratio of 1.31 suggest the premium is partially justified by its 26.9% revenue growth and 24.2% net margin, which are well above industry norms. Historically, the stock's P/E is near the upper end of its 5-year range (30x-45x), indicating the market is pricing in optimistic expectations. Relative to its own history and peers, MNST appears overvalued, but the premium reflects its superior growth and profitability. The market expects continued double-digit growth and margin expansion.
Monster Beverage is a high-quality company with accelerating revenue growth (26.9% YoY) and strong profitability (24.2% net margin), but its premium valuation (39.3x trailing P/E) limits upside potential. The average analyst target of $91.90 implies a -5.7% downside from the current price of $97.50, suggesting the stock is fully valued. For long-term investors with a growth bias, MNST can be a good buy on pullbacks below $90, where the P/E would be more attractive. However, for short-term traders, the risk of a correction toward the 52-week low of $58.09 (40.4% downside) makes it a hold. The biggest risk is competitive pressure from Celsius, which could compress multiples.
Monster Beverage is best suited for long-term investment due to its strong competitive position, accelerating growth, and low beta (0.53) providing stability. The company's zero debt and $2.072B free cash flow support sustained reinvestment and shareholder returns. Short-term trading is riskier given the premium valuation and potential for a correction toward the analyst average target. A minimum holding period of 3-5 years is recommended to allow the growth story to play out and for the premium valuation to be justified by earnings. The stock does not pay a dividend, so total return depends on capital appreciation. For long-term investors, MNST offers a quality growth compounder with lower volatility.
